V. Soontornniyomkij et al., Absence of brain-derived neurotrophic factor and trkB receptor immunoreactivity in glia of Alzheimer's disease, ACT NEUROP, 98(4), 1999, pp. 345-348
Alterations in the neuronal expression of some neurotrophins have been show
n in various neurodegenerative processes, particularly Alzheimer's disease
(AD). Glia may up-regulate neurotrophins and their high-affinity tyrosine k
inase (trk) receptors in response to neural injury. In human immunodeficien
cy virus type 1 (HIV-1) encephalitis, activated microglia were shown to exp
ress brain-derived neurotrophic factor (BDNF), while reactive astrocytes ex
pressed trkB receptor. This observation has suggested the existence of loca
l neurotrophic regulation between different glial populations. To character
ize the glial cellular distribution of BDNF and trkB receptor proteins in,A
D, we studied selected regions of postmortem brains from four AD and three
age-matched control patients by double- immunofluorescence confocal microsc
opy. In both groups, BDNF immunoreactivity was distributed in neuronal peri
karya and neuritic processes in the neocortex and hippocampus. No BDNF immu
noreactivity was observed in microglia or astrocytes within and between sen
ile plaques of AD. Catalytic trkB receptor immunoreactivity was present in
neuronal perikarya in the neocortex and hippocampus. Reactive astrocytes an
d microglia were not immunoreactive for catalytic trkB. The absence of BDNF
and trkB proteins in glia in AD patients is in contrast to the finding in
patients with HIV-1 encephalitis. This difference suggests that glial expre
ssion of BDNF and trkB proteins may be characteristic of particular disease
processes, rather than merely representing a stereotyped response to any t
ype of neural injury.